Key result
Hyperglycaemia induces cardiac dysfunction in rats via TSPO/VDAC1 upregulation and mitochondrial impairment.
Why the study?
Does hyperglycaemia induce myocardial injury via TSPO/VDAC1 upregulation and MMP-2 localization in Sprague-Dawley rats?
Does hyperglycaemia induce myocardial injury via TSPO/VDAC1 upregulation and MMP-2 localization in Sprague-Dawley rats?
In a rat model of diabetic cardiomyopathy, hyperglycaemia induces mitochondrial impairment characterized by TSPO/VDAC1 upregulation and dysregulation of MMP-2 isoforms.
Should not change diabetic cardiomyopathy management; leaves open whether MMP-2 or TSPO/VDAC1 modulation offers human therapeutic targets.
Clinical management of diabetic cardiomyopathy represents an unmet need owing to insufficient knowledge about the molecular mechanisms underlying the dysfunctional heart. The aim of this work is to better clarify the role of matrix metalloproteinase 2 (MMP-2) isoforms and of translocator protein (TSPO)/voltage-dependent anion-selective channel 1 (VDAC1) modulation in the development of hyperglycaemia-induced myocardial injury. Hyperglycaemia was induced in Sprague-Dawley rats through a streptozocin injection (35 mg/Kg, i.p.). After 60 days, cardiac function was analysed by echocardiography. Nicotinamide Adenine Dinucleotide Phosphate NADPH oxidase and TSPO expression was assessed by immunohistochemistry. MMP-2 activity was detected by zymography. Superoxide anion production was estimated by MitoSOX™ staining. Voltage-dependent anion-selective channel 1 (VDAC-1), B-cell lymphoma 2 (Bcl-2), and cytochrome C expression was assessed by Western blot. Hyperglycaemic rats displayed cardiac dysfunction; this response was characterized by an overexpression of NADPH oxidase, accompanied by an increase of superoxide anion production. Under hyperglycaemia, increased expression of TSPO and VDAC1 was detected. MMP-2 downregulated activity occurred under hyperglycemia and this profile of activation was accompanied by the translocation of intracellular N-terminal truncated isoform of MMP-2 (NT-MMP-2) from mitochondria-associated membrane (MAM) into mitochondria. In the onset of diabetic cardiomyopathy, mitochondrial impairment in cardiomyocytes is characterized by the dysregulation of the different MMP-2 isoforms. This can imply the generation of a "frail" myocardial tissue unable to adapt itself to stress.
No takes yet. Share an insight, caveat, or question.
Gliozzi et al. (2020) studied Diabetic cardiomyopathy. Hyperglycaemia (streptozocin injection) was evaluated on Cardiac function and molecular markers (MMP-2, TSPO, VDAC1). Hyperglycaemia in rats induced cardiac dysfunction characterized by TSPO/VDAC1 upregulation and dysregulation of MMP-2 isoforms, leading to mitochondrial impairment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: